PHARMACY

FDA approves Merck’s Winrevair
Winrevair is used for the treatment of adults with pulmonary arterial hypertension to increase exercise capacity, improve WHO functional class and reduce the risk of clinical worsening events.
Amneal to pay over $270M for role in opioid crisis
New York Attorney General Letitia James has secured more than $2.7 billion in total for New York from opioid manufacturers, distributors and marketers.

Walgreens, Boehringer Ingelheim collaborate to improve diversity in clinical trials

The collaboration will offer people an opportunity to learn about and potentially participate in a Phase III clinical trial within Walgreens pharmacies.
Lupin rolls out Rymti biosimilar Etanercept in Canada

Rymti is indicated for the treatment of arthritis, severe axial spondyloarthritis and plaque psoriasis.
NACDS to Congress: Make PBM reform a priority in Change Healthcare cyberattack hearings

NACDS submitted the statement before Wednesday’s House Energy and Commerce Subcommittee on Oversight and Investigations and Senate Finance Committee hearings examining the impact of the Change Healthcare cyberattack.
Dr. Reddy's releases generic Oracea

Generic Oracea is indicated for the treatment of inflammatory lesions of rosacea in adult patients.
Intuity Medical’s POGO Automatic Blood Glucose Monitor now covered by Medicare

CMS has established new Medicare coverage codes for the automatic blood glucose monitor.
Walgreens’ gummy mango candy goes viral

The peelable gummies have become widely popular on TikTok.
FDA approves Boehringer Ingelheim’s high-concentration formulation of interchangeable Humira biosimilar

Cyltezo, the company’s interchangeable biosimilar to Humira, is used to treat multiple chronic inflammatory diseases.
Alvotech to manufacture Humira biosimilar for Quallent Pharmaceuticals

The high-concentration interchangeable biosimilar to AbbVie Biotechnology's Humira manufactured by Alvotech will be distributed under Quallent’s private-label.